A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients (Q80421968)
Jump to navigation
Jump to search
scientific article published on 01 June 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients |
scientific article published on 01 June 2007 |
Statements
A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients (English)
Jos H Beijnen
Jan H M Schellens
Isa E L M Kuppens
Els O Witteveen
Roxanne C Jewell
Sandra A Radema
Elaine M Paul
Steve G Mangum